p21 and CK2 interaction-mediated HDAC2 phosphorylation modulates KLF4 acetylation to regulate bladder cancer cell proliferation
- 358 Downloads
Krüppel-like factor 4 (KLF4) is a transcription factor involved in both tumor suppression and oncogenesis as a transcriptional activator or repressor in a context-dependent manner. KLF4 acts as a regulator of p53 depending on p21 status in breast cancer. However, the mechanisms underlying the distinct role of KLF4 remain poorly understood. Here, we revealed that p21 depletion converted KLF4 from a cell cycle inhibitor to a promoter of bladder cancer cell proliferation. Additionally, KLF4 was acetylated in a p21-dependent manner to inhibit bladder cancer cell growth as a tumor suppressor. However, deacetylated KLF4 functioned as an oncogene promoting bladder cancer cell proliferation. Mechanistically, p21 and CK2 interaction, but not CK2 alone, enhanced HDAC2 phosphorylation and restricted KLF4 deacetylation and subsequent tumor promotion. Furthermore, we observed that KLF4 was acetylated by CBP/p300 and that overexpression of CBP resulted in KLF4 acetylation and tumor suppression even in p21-depleted bladder cancer cells. Moreover, we discovered that Notch-1 knockdown-induced KLF4 is acetylated form of KLF4, which may mediate Notch-1 function in bladder cancer cell proliferation. Our data demonstrate that KLF4 acts as a tumor suppressor or oncogene to activate or repress target gene transcription depending on its acetylation status, which is regulated by p21 and CK2 interaction-mediated HDAC2 phosphorylation. Targeting KLF4 at the post-transcriptional levels may provide novel insight for bladder cancer therapy.
KeywordsCK2 HDAC2 phosphorylation KLF4 acetylation Notch-1 p21
This project was supported by “Military General Hospital of Beijing PLA Innovation Cultivation Fund 2015-LC-13.”
Compliance with ethical standard
Conflicts of interest
The authors declare that they have no conflict of interest.
- 3.Junttila TT, Laato M, Vahlberg T, Soderstrom KO, Visakorpi T, Isola J, et al. Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific erbb4 isoforms: real-time reverse transcription-pcr analysis in estimation of ErbB receptor status from cancer patients. Clinical Cancer Research. 2003;9:5346–57.PubMedGoogle Scholar
- 7.Tien YT, Chang MH, Chu PY, Lin CS, Liu CH, Liao AT. Downregulation of the KLF4 transcription factor inhibits the proliferation and migration of canine mammary tumor cells. Vet J. 2015.Google Scholar
- 11.Zhang W, Geiman DE, Shields JM, Dang DT, Mahatan CS, Kaestner KH, et al. The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the P21WAF1/Cip1 promoter. The Journal of Biological Chemistry. 2000;275:18391–8.CrossRefPubMedPubMedCentralGoogle Scholar
- 21.Foster KW, Ren S, Louro ID, Lobo-Ruppert SM, McKie-Bell P, Grizzle W, et al. Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-myc and the zinc finger protein GKLF. Cell Growth & Differentiation. 1999;10:423–34.Google Scholar
- 25.Meng F, Han M, Zheng B, Wang C, Zhang R, Zhang XH, et al. All-trans retinoic acid increases Klf4 acetylation by inducing HDAC2 phosphorylation and its dissociation from Klf4 in vascular smooth muscle cells. Biochemical and Biophysical Research Communications. 2009;387:13–8.CrossRefPubMedGoogle Scholar
- 30.Wang J, Place RF, Huang V, Wang X, Noonan EJ, Magyar CE, et al. Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Research. 2010;70:10182–91.CrossRefPubMedPubMedCentralGoogle Scholar